NC Euphora™ NCEUP2506XRecalls & reported problems
Medtronic, Inc. · BALLOON NCEUP2506X NCEUPHORA RX US · Class 2
All models of NC Euphora (40)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169395954), received between Oct 27, 2017 and Dec 19, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Burst Container or Vessel1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 19, 2017Burst Container or Vessel; Burst Container or Vessel
IT WAS REPORTED THAT A PHYSICIAN WAS USING AN NC EUPHORA DEVICE TO TREAT A NON-TORTUOUS AND SEVERELY CALCIFIED LESION IN THE PROXIMAL CX ARTERY. THE PHYSICIAN WAS USING THE NC EUPHORA BALLOON CATHETER TO FURTHER EXPAND A PREVIOUSLY DEPLOYED NON MEDTRONIC STENT, THAT HAD BEEN IMPLANTED 1 WEEK PREVIOUSLY. THE PREVIOUSLY IMPLANTED STENT WAS DETERMINED TO BE UNDER EXPANDED BY 50%. NO DAMAGE WAS NOTED TO THE PACKAGING AND NO ISSUES WERE IDENTIFIED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE LESION WAS PRE DILATED. NO RESISTANCE WAS NOTED DURING DELIVERY OF THE DEVICE TO THE LESION, OR DURING WITHDRAWAL OF THE DEVICE FROM THE LESION. THE DEVICE PASSED THROUGH THE PREVIOUSLY DEPLOYED STENT. EXCESSIVE FORCE WAS NOT USED. IT WAS REPORTED THAT THE PREVIOUSLY DEPLOYED STENT WAS NOT ABLE TO FULL EXPAND WHEN IMPLANTED. THE PATIENT WAS BROUGHT BACK FOR LASER AND FURTHER STENT EXPANSION WAS REQUIRED DUE TO HEAVY CALCIFICATION OF THE VESSEL, AND STENOSIS INSIDE OF THE PREVIOUSLY IMPLANTED STENT. THE NC EUPHORA WAS INFLATED TO 34 ATM, AND IT WAS THEN NOTED THAT THE SHAFT OF THE DEVICE BECAME DEFORM
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7127921 ↗MalfunctionOct 27, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PHYSICIAN INTENDED TO USE A NC EUPHORA PTCA BALLOON CATHETER TO TREAT A NON-TORTUOUS AND NON-CALCIFIED LESION LOCATED IN THE DISTAL RIGHT CORONARY ARTERY. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE DEVICE WAS INSPECTED WITH NO ISSUES IDENTIFIED. THE LESION WAS PRE-DILATED. THERE WAS NO RESISTANCE ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. IT WAS REPORTED THAT THE BALLOON WAS EXPIRED (APPROX 31 DAYS PAST ITS EXPIRATION DATE). IN A STEMI CASE THE PHYSICIAN REQUESTED A EUPHORA BALLOON 2.5 X 6 RX AND THE STAFF RETRIEVED THE UNIT FROM THE INVENTORY AREA. BEFORE THE PACKAGE WAS OPENED, IT WAS THEN NOTED BY THE STAFF THE UNIT HAD AN EXPIRATION DATE OF 9-1-2017 AND THE PHYSICIAN WAS INFORMED. THE PHYSICIAN REQUESTED TO OPEN THE PACKAGE AND USE THE BALLOON WITH FULL KNOWLEDGE OF THE EXPIRATION DATE. NO INTERVENTION WAS USED. PATIENT STATUS POST-PROCEDURE IS ALIVE WITH NO INJURY. PATIENT IS STABLE AND WAS DISCHARGED FROM HOSPITAL.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6982786 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page